8 research outputs found
Standardized difference between statin users and non users.
<p>Abbreviations: BMI = body mass index, HCV = hepatitis C virus, HBs = hepatitis B, AIDS = acquired immune deficiency syndrome.</p
Characteristics of the study patients.
<p>Table entries are n (%), mean ± standard deviation, or median (interquartile range), as appropriate.</p><p>Index date: date of MI diagnosis.</p><p>MSM: men having sex with men, BMI: body mass index, AIDS: acquired immune deficiency syndrome, HCV: hepatitis C virus, HBs: hepatitis B surface.</p><p>* p values were calculated including missing data.</p><p><sup>†</sup> Within three months prior to the index date.</p><p>Characteristics of the study patients.</p
Twelve Months of Routine HIV Screening in 6 Emergency Departments in the Paris Area: Results from the ANRS URDEP Study
<div><h3>Objective</h3><p>In October 2009 the French National Authority for Health recommended that HIV testing be proposed at least once to all persons aged 15 to 70 years in all healthcare settings. We examined whether routine HIV screening with a rapid test in emergency departments (EDs) was feasible without dedicated staff, and whether newly diagnosed persons could be linked to care.</p> <h3>Methods</h3><p>This one-year study started in December 2009 in 6 EDs in the Paris area, using the INSTI™ test. Eligible individuals were persons 18 to 70 years old who did not present for a vital emergency, for blood or sexual HIV exposure, or for HIV screening. Written informed consent was required.</p> <h3>Results</h3><p>Among 183 957 eligible persons, 11 401 were offered HIV testing (6.2%), of whom 7936 accepted (69.6%) and 7215 (90.9%) were tested (overall screening rate 3.9%); 1857 non eligible persons were also tested. Fifty-five new diagnoses of HIV infection were confirmed by Western blot (0.61% (95% CI 0.46–0.79). There was one false-positive rapid test result. Among the newly diagnosed persons, 48 (87%) were linked to care, of whom 36 were not lost to follow-up at month 6 (75%); median CD4 cell count was 241/mm<sup>3</sup> (IQR: 52–423/mm<sup>3</sup>).</p> <h3>Conclusions</h3><p>Screening rates were similar to those reported in opt-in studies with no dedicated staff. The rate of new diagnoses was similar to that observed in free anonymous test centres in the Paris area, and well above the prevalence (0.1%) at which testing has been shown to be cost-effective.</p> </div
Factors associated with being newly diagnosed HIV-seropositive among eligible tested persons.
<p>Factors associated with being newly diagnosed HIV-seropositive among eligible tested persons.</p
Summary of studies reporting non targeted HIV screening program in emergency departments, using rapid test since 2006.
<p>Summary of studies reporting non targeted HIV screening program in emergency departments, using rapid test since 2006.</p
Characteristics of newly identified HIV infected individuals linked to care according to whether they were eligible or not.
<p>Characteristics of newly identified HIV infected individuals linked to care according to whether they were eligible or not.</p
Flow-chart of procedures for HIV screening with a rapid test in the ANRS URDEP study.
<p>Flow-chart of procedures for HIV screening with a rapid test in the ANRS URDEP study.</p
Results of a 12 month routine HIV screening program with a rapid test after written inform consent in eligible patients at 6 university hospital emergency departments (EDs) in Paris area (2009–2011).
<p>Results of a 12 month routine HIV screening program with a rapid test after written inform consent in eligible patients at 6 university hospital emergency departments (EDs) in Paris area (2009–2011).</p